Speece Thorson Capital Group Inc. increased its stake in shares of Steris Corp. (NYSE:STE) by 1.3% during the second quarter, according to its most recent 13F filing with the SEC. The fund owned 76,989 shares of the company’s stock after buying an additional 1,012 shares during the period. Speece Thorson Capital Group Inc.’s holdings in Steris Corp. were worth $5,293,000 at the end of the most recent reporting period.
A number of other hedge funds also recently bought and sold shares of the stock. Raymond James Trust N.A. boosted its stake in Steris Corp. by 7.3% in the second quarter. Raymond James Trust N.A. now owns 5,218 shares of the company’s stock valued at $359,000 after buying an additional 357 shares in the last quarter. Benjamin F. Edwards & Company Inc. boosted its stake in Steris Corp. by 4.8% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 7,973 shares of the company’s stock valued at $548,000 after buying an additional 362 shares in the last quarter. Capstone Asset Management Co. boosted its stake in Steris Corp. by 7.4% in the second quarter. Capstone Asset Management Co. now owns 8,780 shares of the company’s stock valued at $604,000 after buying an additional 608 shares in the last quarter. Miles Capital Inc. boosted its stake in Steris Corp. by 28.7% in the first quarter. Miles Capital Inc. now owns 5,114 shares of the company’s stock valued at $363,000 after buying an additional 1,141 shares in the last quarter. Finally, Aviance Capital Management LLC boosted its stake in Steris Corp. by 9.7% in the second quarter. Aviance Capital Management LLC now owns 13,856 shares of the company’s stock valued at $953,000 after buying an additional 1,222 shares in the last quarter. 91.58% of the stock is currently owned by hedge funds and other institutional investors.
Steris Corp. (NYSE:STE) traded up 0.14% during mid-day trading on Tuesday, reaching $73.12. 368,281 shares of the company’s stock traded hands. The stock has a market capitalization of $6.30 billion, a PE ratio of 42.00 and a beta of 1.16. The firm’s 50-day moving average price is $71.24 and its 200 day moving average price is $70.16. Steris Corp. has a 12 month low of $61.38 and a 12 month high of $78.77.
Steris Corp. (NYSE:STE) last issued its earnings results on Tuesday, August 9th. The company reported $0.79 EPS for the quarter, topping the consensus estimate of $0.77 by $0.02. The firm earned $638.40 million during the quarter, compared to analysts’ expectations of $639.04 million. Steris Corp. had a return on equity of 10.72% and a net margin of 5.52%. Steris Corp.’s quarterly revenue was up 45.1% compared to the same quarter last year. During the same period last year, the business earned $0.62 earnings per share. Equities research analysts predict that Steris Corp. will post $3.90 EPS for the current year.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 27th. Investors of record on Tuesday, August 30th will be given a $0.28 dividend. This is a boost from Steris Corp.’s previous quarterly dividend of $0.25. This represents a $1.12 annualized dividend and a yield of 1.53%. The ex-dividend date of this dividend is Friday, August 26th. Steris Corp.’s dividend payout ratio (DPR) is 68.71%.
Several analysts recently issued reports on the stock. Zacks Investment Research cut shares of Steris Corp. from a “hold” rating to a “sell” rating in a report on Wednesday, August 3rd. Northcoast Research upgraded shares of Steris Corp. from a “neutral” rating to a “buy” rating in a research note on Friday, June 3rd.
In related news, insider Adrian Vincent Coward sold 15,000 shares of the firm’s stock in a transaction on Wednesday, August 31st. The stock was sold at an average price of $69.00, for a total value of $1,035,000.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Sudhir K. Pahwa sold 1,028 shares of the stock in a transaction on Friday, August 26th. The stock was sold at an average price of $70.13, for a total value of $72,093.64. The disclosure for this sale can be found here. 2.52% of the stock is owned by corporate insiders.
About Steris Corp.
STERIS Corporation (STERIS) is a provider of infection prevention and other procedural products and services. The Company is focused on healthcare, pharmaceutical and research. The Company operates through three business segments: Healthcare, Life Sciences and STERIS Isomedix Services. The Healthcare segment provides surgical, sterile processing, infection prevention and gastrointestinal solutions.
Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Steris Corp. (NYSE:STE).
Receive News & Ratings for Steris Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Corp. and related companies with MarketBeat.com's FREE daily email newsletter.